Risk of Asthma Exacerbation, Asthma-Related Health Care Utilization and Costs, and Adherence to Controller Therapy in Patients with Asthma Receiving Fluticasone Propionate/Salmeterol Inhalation Powder 100 μg/50 μg Versus Mometasone Furoate Inhalation Powder

2013 ◽  
Vol 50 (3) ◽  
pp. 287-295 ◽  
Author(s):  
May Hagiwara ◽  
Thomas E. Delea ◽  
Richard H. Stanford
Sign in / Sign up

Export Citation Format

Share Document